Float Short %

5.45

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

-0.12

EPS Last/This Y

-0.09

EPS This/Next Y

-0.1

Price

17.01

Target Price

32.57

Analyst Recom

1.57

Performance Q

-15.76

Relative Volume

2.92

Beta

0.75

Ticker: NVCR

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-05-08	NVCR	17.43	0.10	0.07	19732
2025-05-09	NVCR	17.39	0.10	1.02	19726
2025-05-12	NVCR	18.59	0.10	0.04	19754
2025-05-13	NVCR	18.14	0.10	0.29	19855
2025-05-14	NVCR	17.09	0.10	0.37	20057
2025-05-15	NVCR	17.57	0.10	0.17	20183
2025-05-16	NVCR	17.88	0.10	0.03	20397
2025-05-19	NVCR	17.96	0.09	0.18	18366
2025-05-20	NVCR	18.19	0.09	0.49	18446
2025-05-21	NVCR	17.67	0.09	0.05	18558
2025-05-22	NVCR	18.09	0.09	0.07	18884
2025-05-23	NVCR	18.56	0.09	0.03	19088
2025-05-27	NVCR	19.22	0.09	0.01	19139
2025-05-28	NVCR	19.37	0.09	0.02	19383
2025-05-29	NVCR	19.4	0.08	0.06	21643
2025-05-30	NVCR	19.13	0.08	1.21	21646
2025-06-02	NVCR	17.02	0.09	0.40	21863
2025-06-03	NVCR	17.06	0.10	0.28	23216
2025-06-04	NVCR	16.73	0.11	0.02	23524
2025-06-05	NVCR	16.44	0.10	0.14	23818
2025-06-06	NVCR	16.98	0.10	0.43	24220
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-05-08	NVCR	17.42	-25.8	-92.9	-1.65
2025-05-09	NVCR	17.39	-25.8	-81.7	-1.65
2025-05-12	NVCR	18.57	-25.8	-97.9	-1.65
2025-05-13	NVCR	18.14	-25.8	-77.1	-1.65
2025-05-14	NVCR	17.09	-25.8	-69.3	-1.65
2025-05-15	NVCR	17.58	-25.8	-88.6	-1.65
2025-05-16	NVCR	17.88	-25.8	-86.1	-1.65
2025-05-19	NVCR	17.96	-25.8	-83.2	-1.65
2025-05-20	NVCR	18.20	-25.8	-85.4	-1.65
2025-05-21	NVCR	17.77	-25.8	-77.1	-1.65
2025-05-22	NVCR	18.11	-25.8	-86.9	-1.65
2025-05-23	NVCR	18.54	-25.8	-87.7	-1.65
2025-05-27	NVCR	19.18	-25.8	-90.0	-1.65
2025-05-28	NVCR	19.38	-25.8	-84.7	-1.65
2025-05-29	NVCR	19.41	-25.8	-82.8	-1.65
2025-05-30	NVCR	19.11	-25.8	-79.0	-1.65
2025-06-02	NVCR	17.02	-25.8	-57.9	-1.65
2025-06-03	NVCR	17.04	-25.8	-82.8	-1.65
2025-06-04	NVCR	16.71	-25.8	-77.9	-1.65
2025-06-05	NVCR	16.45	-25.8	-78.7	-1.65
2025-06-06	NVCR	17.01	-25.8	-90.2	-1.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-05-08	NVCR	-0.39	-5.56	5.15
2025-05-09	NVCR	-0.39	-5.56	5.15
2025-05-12	NVCR	-0.39	-2.28	5.46
2025-05-13	NVCR	-0.39	-2.28	5.46
2025-05-14	NVCR	-0.39	-2.28	5.46
2025-05-15	NVCR	-0.39	-2.28	5.46
2025-05-16	NVCR	-0.39	-2.28	5.46
2025-05-19	NVCR	-0.38	-0.07	5.50
2025-05-20	NVCR	-0.36	-0.07	5.50
2025-05-21	NVCR	-0.36	-0.07	5.50
2025-05-22	NVCR	-0.36	-0.07	5.50
2025-05-23	NVCR	-0.36	-0.07	5.50
2025-05-27	NVCR	-0.36	3.27	5.50
2025-05-28	NVCR	-0.36	3.27	5.45
2025-05-29	NVCR	-0.36	3.27	5.45
2025-05-30	NVCR	-0.36	3.27	5.45
2025-06-02	NVCR	-0.36	4.06	5.45
2025-06-03	NVCR	-0.36	4.06	5.45
2025-06-04	NVCR	-0.67	4.06	5.45
2025-06-05	NVCR	-0.67	4.06	5.45
2025-06-06	NVCR	-0.67	4.06	5.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.31

Avg. EPS Est. Current Quarter

-0.39

Avg. EPS Est. Next Quarter

-0.43

Insider Transactions

-0.67

Institutional Transactions

4.06

Beta

0.75

Average Sales Estimate Current Quarter

153

Average Sales Estimate Next Quarter

156

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

92.7

Max Drawdown 5-Year %

-95.1

Target Price

32.57

P/E

Forward P/E

PEG

P/S

3.05

P/B

5.24

P/Free Cash Flow

EPS

-1.51

Average EPS Est. Cur. Y

-1.65

EPS Next Y. (Est.)

-1.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-26.41

Relative Volume

2.92

Return on Equity vs Sector %

-69.4

Return on Equity vs Industry %

-63.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-90.2

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1488

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y